Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 113, Issue 3, 635-645, January 15, 2009
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications
Blood Chng et al. 113: 635

Supplemental materials for: Chng et al

Supplemental Methods

Network Analysis
To assess possible interactions between differentially expressed genes, we performed pathway / network analysis using a Web-based software tool, MetaCore™ (GeneGo Inc, St Joseph, MI, USA). MetaCore™ contains an interactive, manually annotated database derived from literature publications on proteins and small molecules that allows for representation of biological functionality and integration of functional, molecular, or clinical information.1 Several algorithms to enable both the construction and analysis of gene networks are integrated as previously described. The output p-values reflect scoring, prioritization and statistical significance of networks according to relevance of input data.

Gene Set Enrichment Analysis (GSEA)
GSEA has been described elsewhere.2 There are three main elements to the GSEA methods. First an enrichment score (ES) that reflects the degree to which a gene set S is overrepresented at the extremes (top or bottom) of the entire ranking list L. A weighted Kolmogorov-Smirnov–like statistic is used. The statistical significance (norminal p-value) of the ES is estimated by using an empirical phenotype-based permutation test procedure that preserves the complex correlation structure of the gene expression data. Specifically, a null distribution of the ES was generated by permutating the phenotype labels and recomputing the ES of the gene set for the permutated labels. The nominal p-value of the observed ES is then calculated relative to this null distribution. When an entire database of gene sets is evaluated, the estimated significance level is adjusted to account for multiple hypothesis testing. The ES is first normalized for each gene set to account for the size of the set. Proportion of false positives is controlled by calculated the FDR which is computed by comparing the tails of the observed and null distribution for the normalized ES. The goal of GSEA is to determine whether the members of S are randomly distributed throughout L or primarily found at the top or bottom, in which case the gene set is correlated with the phenotypic class distinction. The ranking metric used was Signal2Noise, and the phenotype was permutated with 1000 permutations to estimate the statistical significance of enrichment. FDR was controlled at 5%. The C1: position, C2: curated, and C3: promoter motifs gene-sets were analyzed.

REFERENCES

1. Nikolsky Y, Ekins S, Nikolskaya T, Bugrim A. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett. 2005;158:20–29.
2. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545–15550.

Files in this Data Supplement:





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020